European Union - English - EMA (European Medicines Agency)

elanco gmbh - pyriprole - ectoparasiticides for topical use, incl. insecticides - dogs - treatment and prevention of flea infestation (ctenocephalides canis and c. felis) in dogs. efficacy against new infestations with fleas persists for a minimum of 4 weeks.treatment and prevention of tick infestation (ixodes ricinus, rhipicephalus sanguineus, ixodes scapularis, dermacentor reticulatus, dermacentor variabilis, amblyomma americanum) in dogs. efficacy against ticks persists for 4 weeks.

New Zealand - English - Ministry for Primary Industries

elanco australasia pty ltd - pyriprole - pyriprole 125 g/litre - ectoparasiticide

Philippines - English - FDA (Food And Drug Administration)

novartis healthcare philippines, inc. business unit animal health; distributor: novartis healthcare philippines, inc. business unit animal health - pyriprole (vet.) - spot-on solution - 137.5mg/ 1.1ml

Philippines - English - FDA (Food And Drug Administration)

eli lilly (philippines), inc.; distributor: eli lilly (philippines), inc. - pyriprole (vet.) - spot-on solution - 625mg/5ml

Philippines - English - FDA (Food And Drug Administration)

eli lilly (philippines), inc.; distributor: eli lilly (philippines), inc. - pyriprole (vet.) - spot-on solution - 56.25mg/0.45ml

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco gmbh - pyriprole - spot-on solution - ectoparasiticide - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco gmbh - pyriprole - spot-on solution - ectoparasiticide - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco gmbh - pyriprole - spot-on solution - ectoparasiticide - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco gmbh - pyriprole - spot-on solution - ectoparasiticide - dogs

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.